- On **October 9, 2025**, MEDIROM Healthcare Technologies Inc. announced that its subsidiary, MEDIROM MOTHER Labs Inc., approved a **Series A equity financing round**.  **[1819704_0001104659-25-098069_mrm-20251009x6k.htm:0]** **[1819704_0001104659-25-098069_mrm-20251009xex99d1.htm:0]** 
- The Series A round valued MEDIROM MOTHER Labs Inc. at **JPY9 billion**.  **[1819704_0001104659-25-098069_mrm-20251009xex99d1.htm:0]** 
- The financing involves a **private placement of new shares** to two officers of MOTHER Labs, Yoshio Uekusa and Ryo Saito, with funding scheduled to occur by the **end of October**.  **[1819704_0001104659-25-098069_mrm-20251009xex99d1.htm:0]** 
- The capital increase aims to strengthen the subsidiary's capital base, accelerate the development of an upgraded MOTHER Bracelet, and establish systems for bringing products to market.  **[1819704_0001104659-25-098069_mrm-20251009xex99d1.htm:0]**

MEDIROM Healthcare Technologies Subsidiary Completes Series A Funding

- **MEDIROM Healthcare Technologies Inc. (MRM)** announced its **Key Performance Indicators (KPIs)** for **August 2025**, reporting **82,780 total customers served** and **JPY 7,530 sales per customer** in its salon operation business.  **[1819704_0001104659-25-092716_mrm-20250924xex99d1.htm:0]** 
- The salon operation business achieved a **customer repeat ratio of 76.5%** and an **operation ratio of 48.4%** in August 2025, representing a **year-over-year increase from 47.3%**.  **[1819704_0001104659-25-092716_mrm-20250924xex99d1.htm:0]** 
- As of August 2025, the company operated **299 salons**.  **[1819704_0001104659-25-092716_mrm-20250924xex99d1.htm:0]** 
- In its Health Tech Business, the cumulative number of contracts with corporate insurance associations reached **101**, and the Lav® app had a cumulative total of **10,951 users**.  **[1819704_0001104659-25-092716_mrm-20250924xex99d1.htm:1]**

MEDIROM Healthcare Technologies Inc. Announces August 2025 Key Performance Indicators

- **MEDIROM Healthcare Technologies Inc.** announced that its subsidiary, **MEDIROM MOTHER Labs Inc.**, has begun providing its **REMONY remote health monitoring system** to the **Japan Ground Self-Defense Force (JGSDF)**.  **[1819704_0001104659-25-091290_mrm-20250918xex99d1.htm:0]** 
- The REMONY system is powered by the **recharge-free smart tracker _MOTHER Bracelet®_**, which utilizes thermoelectric generation technology for uninterrupted operation without requiring recharging.  **[1819704_0001104659-25-091290_mrm-20250918xex99d1.htm:0]** 
- This adoption by the JGSDF 8th Division addresses the need for **lightweight, energy-efficient, and long-term health monitoring** in extreme conditions, enabling real-time health data collection and proactive risk identification, such as heatstroke prevention.  **[1819704_0001104659-25-091290_mrm-20250918xex99d1.htm:0]**

Medirom Healthcare Technologies' Subsidiary's REMONY System Adopted by Japan Ground Self-Defense Force

- On **August 28, 2025**, MEDIROM Healthcare Technologies Inc. announced that its subsidiary's product, **"REMONY for Driver"**, a remote health management system, has been **certified by Japan's Ministry of Land, Infrastructure, Transport and Tourism (MLIT)**.  **[1819704_0001558370-25-011808_mrm-20250828xex99d1.htm:0]** 
- This certification designates "REMONY for Driver" as a device for **preventing fatigue-related driving** under MLIT's *Accident Prevention Support and Promotion Program*.  **[1819704_0001558370-25-011808_mrm-20250828xex99d1.htm:0]** 
- The system utilizes the **MOTHER Bracelet** to centrally manage drivers' health and alertness, featuring a proprietary sleep assessment function.  **[1819704_0001558370-25-011808_mrm-20250828xex99d1.htm:0]** 
- The certification makes the product eligible for a **50% subsidy** on equipment acquisition cost, with MLIT allocating approximately **1.3 billion yen** in subsidies for the previous fiscal year and a similar budget expected for the current year, subject to a cap of **800,000 yen per business operator** for fatigue prevention devices.  **[1819704_0001558370-25-011808_mrm-20250828xex99d1.htm:0]**

Medirom Healthcare Technologies (MRM)